• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELI LILLY AND COMPANY HUMAPEN LUXURA BURGUNDY; FOR TREATMENT PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELI LILLY AND COMPANY HUMAPEN LUXURA BURGUNDY; FOR TREATMENT PURPOSES Back to Search Results
Model Number MS9662
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Hyperglycemia (1905); Loss of consciousness (2418)
Event Date 01/31/2003
Event Type  Injury  
Event Description
Lilly case id: (b)(4).This spontaneous case, reported by a consumer who contacted the company to report adverse events, concerned a male patient of unknown age and origin.Medical history included diabetic since 1993.Concomitant medications were not provided.The patient received insulin lispro (rdna origin) injection (humalog 100u/ml) from cartridge via humapen luxura burgundy, for the treatment of diabetes, beginning on an unspecified date in 2003.He had the humapen luxura burgundy pen for over 10 years (improper use).Dosage, route of administration and frequency of use were not provided.On an unknown date in 2003 or 2010 (conflicting date), while on insulin lispro therapy, the patient was hospitalized due to hypoglycemia presented with mental confusion and loss of consciousness.Information regarding the outcome of event, corrective treatment and further hospitalization details was not provided.Status of insulin lispro therapy was ongoing.The operator of the humapen luxura burgundy was the patient, and his training status was not provided.The device model duration of use and suspect device duration of use were not reported.The action taken with the suspect humapen luxura burgundy was not returned to the manufacturer.The initial reporting consumer did not report the relatedness assessment of the event with the insulin lispro therapy nor with humapen luxura burgundy device.This case is cross referenced with the following cases: (b)(4) and (b)(4) (same patient).Update (b)(6) 2023: information received on 29-sep-2023 from the initial reporter did not include medically significant information.No changes were made to the case.Edit (b)(6) 2023: upon review of information received on 14-jul-2023, improper use or storage field was updated from no to yes and added batch number of humapen luxura burgundy.Updated narrative accordingly.Update (b)(6) 2023: additional information received on 08nov2023 from the global product complaint database.Entered the device specific safety summary (dsss) updated the medwatch and european and canadian (eu/ca) device fields.Corresponding fields and narrative updated accordingly.
 
Manufacturer Narrative
B.5.Narrative field: new, updated, and corrected information is referenced within the update statements in b.5.Please refer to update statement(s) dated 08nov2023 in the b.5.Field.No further follow-up is planned.Evaluation summary: the reporter stated the patient used the humapen luxura burgundy since approximately 2003.There was no product complaint for the device and the device was not returned for investigation.There was evidence of improper use of the device.The patient used the humapen luxura burgundy for approximately twenty years.The humapen luxura burgundy user manual states to not use the pen for more than six years after the first use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HUMAPEN LUXURA BURGUNDY
Type of Device
FOR TREATMENT PURPOSES
Manufacturer (Section D)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis 46285
Manufacturer (Section G)
PHILLIPS-MEDISIZE CORPORATION
medical device manufacturing
415 red cedar street
menomonie 54751
Manufacturer Contact
catherine cassidy
lilly corporate center
indianapolis, IN 46285
3174332191
MDR Report Key18095062
MDR Text Key327665415
Report Number1819470-2023-00051
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K142518
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberMS9662
Device Lot Number1205B01
Was Device Available for Evaluation? No
Date Manufacturer Received07/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient SexMale
-
-